ArticleStem cells international2023

CRISPR/Cas9 Genome Editing in LGMD2A/R1 Patient-Derived Induced Pluripotent Stem and Skeletal Muscle Progenitor Cells.

Lampros Mavrommatis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.